Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: A Bayesian network meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of adjuvant EGFR TKI alone and in combination with chemotherapy for resected EGFR mutation-positive non-small cell lung cancer: A Bayesian network meta-analysis

Published:2023-06 Issue: Volume:186 Page:104010
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Cui Xinrun^ORCID,Li Xiang,Lv Chao,Yan Shi,Wang Jia,Wu Nan

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference51 articles.

1. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer;Baselga;J. Clin. Oncol.,2005

2. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors;Boer;Ann. Oncol.,2015

3. Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer;Burdett;Cochrane Database Syst. Rev.,2015

4. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects;Carver;J. Clin. Oncol.,2007

5. The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer;Chansky;J. Thorac. Oncol.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non‐small cell lung cancer;Chemical Biology & Drug Design;2023-12-18